708 related articles for article (PubMed ID: 26916731)
1. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
[TBL] [Abstract][Full Text] [Related]
2. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
Kleinschnitz C; Pozgajova M; Pham M; Bendszus M; Nieswandt B; Stoll G
Circulation; 2007 May; 115(17):2323-30. PubMed ID: 17438148
[TBL] [Abstract][Full Text] [Related]
3. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
[TBL] [Abstract][Full Text] [Related]
4. Diminished thrombus formation and alleviation of myocardial infarction and reperfusion injury through antibody- or small-molecule-mediated inhibition of selectin-dependent platelet functions.
Oostingh GJ; Pozgajova M; Ludwig RJ; Krahn T; Boehncke WH; Nieswandt B; Schön MP
Haematologica; 2007 Apr; 92(4):502-12. PubMed ID: 17488661
[TBL] [Abstract][Full Text] [Related]
5. Platelet GPIIb/IIIa receptor blockade reduces infarct size in a canine model of ischemia-reperfusion.
Kingma JG; Plante S; Bogaty P
J Am Coll Cardiol; 2000 Dec; 36(7):2317-24. PubMed ID: 11127479
[TBL] [Abstract][Full Text] [Related]
6. A chimeric IgG4 monoclonal antibody directed against CD18 reduces infarct size in a primate model of myocardial ischemia and reperfusion.
Aversano T; Zhou W; Nedelman M; Nakada M; Weisman H
J Am Coll Cardiol; 1995 Mar; 25(3):781-8. PubMed ID: 7860929
[TBL] [Abstract][Full Text] [Related]
7. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody.
Arslan F; Smeets MB; O'Neill LA; Keogh B; McGuirk P; Timmers L; Tersteeg C; Hoefer IE; Doevendans PA; Pasterkamp G; de Kleijn DP
Circulation; 2010 Jan; 121(1):80-90. PubMed ID: 20026776
[TBL] [Abstract][Full Text] [Related]
8. Limitation of reperfusion injury by a monoclonal antibody to C5a during myocardial infarction in pigs.
Amsterdam EA; Stahl GL; Pan HL; Rendig SV; Fletcher MP; Longhurst JC
Am J Physiol; 1995 Jan; 268(1 Pt 2):H448-57. PubMed ID: 7840295
[TBL] [Abstract][Full Text] [Related]
9. Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target.
Ziegler M; Wang X; Peter K
Cardiovasc Res; 2019 Jun; 115(7):1178-1188. PubMed ID: 30906948
[TBL] [Abstract][Full Text] [Related]
10. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.
Bhindi R; Fahmy RG; McMahon AC; Khachigian LM; Lowe HC
J Pathol; 2012 Jun; 227(2):157-64. PubMed ID: 22344601
[TBL] [Abstract][Full Text] [Related]
11. Platelet Serotonin Aggravates Myocardial Ischemia/Reperfusion Injury via Neutrophil Degranulation.
Mauler M; Herr N; Schoenichen C; Witsch T; Marchini T; Härdtner C; Koentges C; Kienle K; Ollivier V; Schell M; Dorner L; Wippel C; Stallmann D; Normann C; Bugger H; Walther P; Wolf D; Ahrens I; Lämmermann T; Ho-Tin-Noé B; Ley K; Bode C; Hilgendorf I; Duerschmied D
Circulation; 2019 Feb; 139(7):918-931. PubMed ID: 30586717
[TBL] [Abstract][Full Text] [Related]
12. The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.
Lu F; Fernandes SM; Davis AE
Cardiovasc Pathol; 2013; 22(1):75-80. PubMed ID: 22705194
[TBL] [Abstract][Full Text] [Related]
13. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
14. Platelets activated by collagen through the immunoreceptor tyrosine-based activation motif in the Fc receptor gamma-chain play a pivotal role in the development of myocardial ischemia-reperfusion injury.
Takaya N; Katoh Y; Iwabuchi K; Hayashi I; Konishi H; Itoh S; Okumura K; Ra C; Nagaoka I; Daida H
J Mol Cell Cardiol; 2005 Dec; 39(6):856-64. PubMed ID: 16246361
[TBL] [Abstract][Full Text] [Related]
15. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by splenectomy or by FTY720 protects the heart against ischemia reperfusion injury.
Goltz D; Huss S; Ramadori E; Büttner R; Diehl L; Meyer R
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1168-77. PubMed ID: 26218889
[TBL] [Abstract][Full Text] [Related]
17. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
[TBL] [Abstract][Full Text] [Related]
18. Red blood cell-derived semaphorin 7A promotes thrombo-inflammation in myocardial ischemia-reperfusion injury through platelet GPIb.
Köhler D; Granja T; Volz J; Koeppen M; Langer HF; Hansmann G; Legchenko E; Geisler T; Bakchoul T; Eggstein C; Häberle HA; Nieswandt B; Rosenberger P
Nat Commun; 2020 Mar; 11(1):1315. PubMed ID: 32161256
[TBL] [Abstract][Full Text] [Related]
19. Activated platelets contribute importantly to myocardial reperfusion injury.
Xu Y; Huo Y; Toufektsian MC; Ramos SI; Ma Y; Tejani AD; French BA; Yang Z
Am J Physiol Heart Circ Physiol; 2006 Feb; 290(2):H692-9. PubMed ID: 16199480
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
